Test Up Now Education Program
TUNE-UP
2 other identifiers
interventional
115
1 country
1
Brief Summary
This study will test the effectiveness of an outreach strategy to increase colorectal cancer screening in African Americans. The investigators will recruit 250 African Americans ages 45-64 years who are not up-to-date with colorectal cancer screening or have never been screened, with the goal to evaluate screening knowledge, behavior, and intervention effects on colorectal cancer screening outcomes. Participants will be randomly assigned to the TUNE-UP intervention or a control group. The TUNE-UP intervention arm will utilize a community health advisor to encourage return of stool blood testing kits through cell phone outreach. The control group will receive educational materials about colorectal cancer screening plus a resource list but no community health advisor counseling support or cellphone / text contact. The primary study outcome is receipt of colorectal cancer screening (colonoscopy or Fecal Immunochemical Test) following the intervention. The secondary outcomes will include colorectal cancer screening knowledge, self-efficacy (confidence to receive colorectal cancer screening), intention to screen, and follow-up in the case of an abnormal test result. The research objective is to test the community health advisor intervention effectiveness for promoting stool blood testing as a preferred screening test in an under-screened African American population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 24, 2020
CompletedFirst Posted
Study publicly available on registry
March 11, 2020
CompletedStudy Start
First participant enrolled
April 7, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 12, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 12, 2024
CompletedResults Posted
Study results publicly available
October 29, 2024
CompletedOctober 29, 2024
April 1, 2024
2.9 years
February 24, 2020
June 11, 2024
October 3, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Number of Participants Up to Date on Colorectal Cancer Screening
The colorectal cancer screening measure asks about completion of colonoscopy and blood stool tests. These tests are described prior to questions about completion of each test. The first question asks when was the most recent stool blood test (\> 1 year but \< 2 years ago; \> 2 years but not more than 5 years ago; or \> 5 years). The second question asks when was the most recent colonoscopy (a year ago or less; \> 1 year but \< 5 years ago; \> 5 years but not more than 10 years ago; or \> 10 years). Colorectal cancer screening receipt will be determined based on self-report and chart review to determine screening rates for each screening modality. Those answering a "a year ago or less" for the most recent stool blood test and "less than 10 years ago" for most recent colonoscopy are considered up to date.
12 months
Secondary Outcomes (2)
Colorectal Cancer Screening Knowledge Measure
12 months
Colorectal Cancer Screening Self-Efficacy Scale
12 months
Study Arms (2)
Community Health Advisor
EXPERIMENTALIntervention arm participants will be scheduled to receive the Community Health Advisor intervention within 4 to 6 weeks after enrollment, a Fecal Immunochemical Test kit, a mailed targeted colorectal cancer brochure, and a follow-up telephone survey at 3- and 12-months post-intervention
Usual care
ACTIVE COMPARATORControl group participants will receive a Fecal Immunochemical Test kit, a mailed targeted colorectal cancer brochure, and complete a follow-up telephone survey at 3- and 12-months after the mailing.
Interventions
Intervention arm participants will receive one 45-minute face-to-face meeting followed by two phone calls in one-week intervals over a period of three weeks beginning within one month following baseline survey completion. These educational activities will include the use of National Cancer Institute colorectal cancer resources and materials, including a Screen to Save media presentation, and colorectal cancer brochures. The intervention will follow a conversation guide/standard script for intervention fidelity. Community Health Advisors will take notes following each interaction to document the call length and call details. Participants will receive an additional text message reminder once a week for an additional three weeks - with instructions for participants to text "yes" to confirm they received the message - for a total of six weeks of intervention delivery. The personalized text messages will include short messages about the benefits of colorectal cancer screening.
Control arm participants will receive a Fecal Immunochemical Test kit, a mailed targeted colorectal cancer brochure, and complete a follow-up telephone survey at 3- and 12-months after the mailing.
Eligibility Criteria
You may qualify if:
- are 45 years to 64 years of age
- self-identify as African American
- have a working cellphone or telephone
- are a resident of Florida
- are non-adherent with colorectal cancer screening guidelines (i.e., no stool-based tests \> 9 months, no colonoscopy within 9 years, and no flexible sigmoidoscopy within 4 years)
- have no personal history of colorectal cancer, precancerous colorectal polyps, or inflammatory bowel disease (ulcerative colitis or Crohn's disease).
You may not qualify if:
- under 45 years or over 64 years of age
- do not self-identify as African American
- do not have a working cellphone or telephone
- not a resident of Florida
- are adherent with colorectal cancer screening guidelines (i.e., stool-based tests \< 9 months, colonoscopy within 9 years, and flexible sigmoidoscopy within 4 years) or
- have a personal history of colorectal cancer, precancerous colorectal polyps, or inflammatory bowel disease (ulcerative colitis or Crohn's disease).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Florida A&M University
Tallahassee, Florida, 323207, United States
Related Publications (2)
Luque JS, Kiros GE, Vargas MA, Ali A, Tawk R, Jackson DR, Dickey SL, Harris CM, Robinson T, Duncan B, Freeman J, Gwede CK, Wallace K. Effectiveness of a community health advisor colorectal cancer screening educational intervention on stool test completion in an African American primary care patient population: a pragmatic randomized controlled trial. BMC Glob Public Health. 2025 Jun 1;3(1):47. doi: 10.1186/s44263-025-00168-4.
PMID: 40450376DERIVEDLuque JS, Matthew OO, Jackson DR, Vargas MA, Austin T, Ali A, Kiros GE, Harris CM, Tawk R, Gwede CK, Wallace K, Jean-Pierre P. Assessing the effectiveness of a community health advisor plus screen to save educational intervention on stool-based testing adherence in an African American safety net clinic population: study protocol for a randomized pragmatic trial. Trials. 2022 Feb 15;23(1):151. doi: 10.1186/s13063-022-06076-4.
PMID: 35168640DERIVED
Limitations and Caveats
The projected sample size was originally 244. Because of difficulties in recruiting this patient population of African American patients in 2 community health centers who were not up to date with colorectal cancer screening, the study was only able to recruit 115 individuals over the 2 year recruitment period. Therefore, there is smaller number of patients to analyze the effectiveness of the educational intervention, and the study is underpowered.
Results Point of Contact
- Title
- Dr. Tanise Jackson, Director of Animal Welfare Research Integrity
- Organization
- Florida A&M University
Study Officials
- PRINCIPAL INVESTIGATOR
Karam Soliman, PhD
Florida A&M University
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Participant will complete surveys and receive mailings and not know if they are in control arm or intervention arm.
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 24, 2020
First Posted
March 11, 2020
Study Start
April 7, 2021
Primary Completion
February 12, 2024
Study Completion
February 12, 2024
Last Updated
October 29, 2024
Results First Posted
October 29, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- 3 years following completion of the project
- Access Criteria
- Data release will require a fully executed data sharing agreement that will place stipulations on the data that will further protect human subjects. This agreement will include the following: 1. Requirement that the data be used for research purposes only, and not for commercial use 2. Requirement that data will be secured using appropriate computer technology (e.g., password protected computers, firewalls) 3. Requirement that no attempt will be made to identify any individual in the study data, and that if any identification does occur the link allowing such identification will be destroyed 4. Requirement that data not be shared with anyone not included in the original data sharing agreement 5. Requirement that a copy of any resulting publications be forwarded to the Principal Investigator for record-keeping purposes and for archiving as required with NIH 6. Requirement that acknowledgment of the data source be made, as appropriate, within the investigator's publication venue
Data sharing will be overseen by the Principal Investigator. To facilitate sharing of data, study outcome publications from this colorectal cancer screening intervention study will provide email contact information for interested persons to obtain details on accessing de-identified data. The data sharing option will be available for at least 3 years following completion of the project, consistent with National Institutes of Health (NIH) policy on maintenance of study data. The investigator requesting the data will be required to submit a data request detailing the research question to be investigated, the specific variables necessary for the intended analyses, a list of individuals who will have access to the data, and proof of adequate training in the protection of human subjects for all individuals with access to data.